We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Introducing the Latest Generation of Low-Throughput Real-Time PCR Instruments

By LabMedica International staff writers
Posted on 20 Jun 2011
A worldwide exclusive OEM agreement will increase the availability of the latest generation of low-throughput real-time PCR instruments for applications such as nucleic acid quantification, gene expression profiling, and detecting genetic variations.

Roche Applied Science (Basel, Switzerland) has signed an agreement with IT-IS Life Sciences Ltd. More...
(Stokesley, United Kingdom) for the distribution of the new LightCycler Nano Instrument.

The LightCycler Nano is a 32-well format real-time PCR cycler with state of the art functionality and easy-to-use software. As it is both silent and compact, this instrument was designed to be an excellent bench-top companion for laboratory end users performing real-time PCR on a daily basis. The system uses convenient, standard PCR strips and can support all common detection dyes with its full spectrum optics.

Roche is the world's largest biotech company with over 80,000 employees and more than nine billion Swiss francs committed to research and development. Regarding the agreement with IT-IS Life Sciences, Roche's head of PCR projects, Gerd Haberhausen, said, "With the LightCycler Nano Instrument, we now provide a very compact and innovative high performance PCR instrument under a worldwide exclusive agreement. The new LightCycler Nano Instrument delivers proven high quality at an affordable price and expands our qPCR business into a new segment. Customers will love the smart design of the instrument and appreciate the high quality data they can produce with it."

Roderic Fuerst, CEO of IT-IS Life Sciences Ltd., said, "We believe that the creative engineering capability of IT-IS and the market leadership position of Roche in real-time PCR are a perfect match for each other. The LightCycler Nano system will deliver exceptional performance, ease of use, and value due to its highly integrated solid-state design."

Related Links:
Roche Applied Science
IT-IS Life Sciences Ltd.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.